Vistagen Therapeutics Inc 's ROA from the first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Vistagen Therapeutics Inc 's ROA in the first quarter of 2026?
Vistagen Therapeutics Inc recorded a cumulative net loss of $-68 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -102.35%.

However, within the Healthcare sector 752 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4257, from total ROA ranking in the fourth quarter of 2026 at 4895.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Total Assets Change	-26.81 %	-42.42 %	-31.79 %	-21.04 %	-39.3 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-68	-70	-67	-62	-56
Return On Assets (TTM)	-102.35 %	-98.58 %	-84.19 %	-69.57 %	-58.81 %
VTGN's Total Ranking	# 4257	# 4895	# 4203	# 4172	# 4131
Total Assets (TTM) in million	50	49	84	81	69
Seq. Total Assets Change	3.87 %	-42.42 %	4.22 %	17.42 %	-18.28 %
Seq. Net Income Change	-	-	-	-	-

VTGN's 5 Years Annual ROA >> Back to VTGN Management Effectiveness >> Compare VTGN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 350
Sector	# 753
Overall	# 4248

Return On Assets Statistics
High	Average	Low
-40.84 %	-835.14 %	-5834.11 %
(Dec 31 2024)		(Jun 30 2015)

Financial Statements
Vistagen Therapeutics Inc 's Assets	$ 50 million	VTGN's Balance sheet
Vistagen Therapeutics Inc 's Income	$ -13 million	Quarterly VTGN's Income Statement
VTGN's Income by Division		See VTGN's Income by Division

Annual Return On Assets	(Mar 31 2026) FY 2026	(Mar 31 2025) FY 2025	(Mar 31 2024) FY 2024	(Mar 31 2023) FY 2023	(Mar 31 2022) FY 2022
Y / Y Total Assets Change	-42.42 %	-31.79 %	486.33 %	-71.75 %	-31.07 %
Total Assets in million	49	84	124	21	75
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-70	-51	-29	-59	-48
Annual Return On Assets	-143.49 %	-60.96 %	-23.75 %	-280.94 %	-63.99 %

VTGN's 5 Years Annual ROA >> Back to VTGN Management Effectiveness >> Compare VTGN ROA to its Competitors

More Return On Assets Ratios
VTGN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VTGN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VTGN's Competitors
Subscribers only: Roa for Vistagen Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for VTGN's Customers

You may also want to know
VTGN's Roi	VTGN's Inventory Turnover Ratio	VTGN's Growth Rates	VTGN's Dividend Comparisons
	VTGN's Profitability Ratios	VTGN's Asset Turnover Ratio	VTGN's Dividend Growth
VTGN's Roe	VTGN's Valuation Ratios	VTGN's Financial Strength Ratios	VTGN's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T22:48:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.